Integer Holdings Corporation logo
Integer Holdings Corporation ITGR
$ 87.73 3.08%

Annual report 2025
added 02-23-2026

report update icon

Integer Holdings Corporation Income Statement 2011-2026 | ITGR

Annual Income Statement Integer Holdings Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.98 B 4.58 B 3.34 B 2.44 B 2.77 B 2.9 B 2.86 B 2.61 B 1.63 B 1.02 B 1.26 B 1.08 B - 639 M 539 M

Shares

34.7 M 33.6 M 33.3 M 33.1 M 33 M 32.8 M 32.6 M 32.6 M 32.1 M 26.4 M 26 M 25.3 M - 23.6 M 23.6 M

Historical Prices

85.7 136 100 73.6 83.9 88.2 90.2 91 51 36.1 37.8 53.1 43.3 27.1 24.8

Net Income

103 M 120 M 90.6 M 66.4 M 96.8 M 77.3 M 96.3 M 168 M 66.7 M -7.59 M 55.5 M 36.3 M - -4.8 M 33.1 M

Revenue

1.85 B 1.72 B 1.56 B 1.33 B 1.22 B 1.07 B 1.26 B 1.22 B 1.14 B 800 M 688 M 664 M - 646 M 569 M

Cost of Revenue

1.35 B 1.26 B 1.15 B 986 M 884 M 788 M 903 M 852 M 782 M 738 M 456 M 445 M - 445 M 388 M

Gross Profit

500 M 459 M 410 M 346 M 337 M 286 M 355 M 363 M 354 M 235 M 231 M 219 M - 202 M 180 M

Operating Income

221 M 208 M 163 M 113 M 136 M 121 M 158 M 156 M 126 M 92.9 M 75.7 M 61.3 M - 25.8 M 61.7 M

Interest Expense

-53.2 M -3.52 M -975 K 899 K 31.6 M 38.2 M 52.5 M 99.3 M 64 M 68.3 M 4.25 M 11.3 M - 18.1 M 16.9 M

EBITDA

352 M 319 M 262 M 205 M 217 M 200 M 244 M 278 M 228 M 57.8 M 113 M 97.3 M - 72.2 M 109 M

Operating Expenses

279 M 251 M 247 M 233 M 201 M 165 M 189 M 173 M 228 M 222 M 156 M 158 M - 176 M 119 M

General and Administrative Expenses

212 M 185 M 173 M 158 M 141 M 109 M 139 M 116 M 120 M 92.8 M 83.6 M 82.3 M - 74.8 M 72.5 M

All numbers in USD currency

Quarterly Income Statement Integer Holdings Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

35.1 M 35 M 33.9 M 33.5 M 33.7 M 33.6 M 33.5 M 33.3 M 33.3 M 33.3 M 33.3 M 33.2 M 33.1 M 33.1 M 33.1 M 33.1 M 33 M 33 M 33 M 32.9 M 32.9 M 32.8 M 32.8 M 32.7 M 32.7 M 32.6 M 32.5 M 32.5 M 32.2 M 32 M 31.9 M 31.9 M 31.6 M 31.3 M 31 M 30.9 M 30.8 M 30.8 M 30.7 M 25.1 M 25.5 M 25.5 M 25.3 M 24.4 M 24.9 M 24.8 M 24.6 M - 24 M 23.9 M 23.8 M 23.7 M 23.6 M 23.6 M 23.4 M 23.4 M 23.3 M 23.2 M 23.2 M

Net Income

39.7 M 37 M -22.5 M - 35.4 M 31.2 M 20.5 M - 27.3 M 24 M 13.1 M - 16.1 M 20.8 M 11.4 M - 22.1 M 29.4 M 21.5 M - 30.3 M 389 K 31.1 M 11 M 30.6 M 33.1 M 21.7 M 19.2 M -8.3 M 23.1 M 13.1 M 54.7 M 19.9 M 9.56 M 2.95 M 7.93 M 11.5 M -770 K -12.7 M 14.2 M 22 K 9.28 M 8.01 M 9.78 M 14 M 12.3 M 14.9 M - 11.1 M 9.75 M 5.66 M -5.56 M -7.56 M 3.85 M 4.47 M 5.64 M 6.99 M 8.55 M 11.9 M

Revenue

468 M 476 M 437 M - 431 M 428 M 408 M - 397 M 400 M 379 M - 343 M 350 M 311 M - 306 M 312 M 290 M 269 M 236 M 240 M 328 M 326 M 304 M 314 M 315 M 303 M 305 M 314 M 382 M 390 M 363 M 281 M 345 M 360 M 347 M 348 M 332 M 170 M 147 M 175 M 161 M 177 M 172 M 172 M 174 M - 168 M 171 M 148 M 159 M 161 M 167 M 159 M 142 M 132 M 147 M 149 M

Cost of Revenue

342 M 347 M 317 M - 315 M 311 M 300 M - 292 M 294 M 282 M - 256 M 257 M 229 M - 224 M 223 M 206 M - 178 M 182 M 232 M - 210 M 217 M 226 M - 213 M 216 M 209 M - 197 M 192 M 254 M - 249 M 252 M 241 M - 95 M 117 M 109 M - 114 M 114 M 117 M - 112 M 114 M 99.5 M - 110 M 115 M 112 M - 89.8 M 99.9 M 102 M

Gross Profit

126 M 129 M 120 M - 117 M 117 M 108 M - 105 M 106 M 96.7 M - 86.7 M 92.9 M 81.5 M - 81.9 M 88.7 M 84.5 M 73.2 M 57.9 M 57.9 M 96.7 M 76 M 93.4 M 97 M 88.6 M 88.4 M 91.9 M 98.8 M 83.5 M 93.6 M 89.2 M 89.2 M 82 M 92.9 M 97.9 M 96 M 91.5 M 57.2 M 51.6 M 58 M 52.4 M 57.4 M 58.1 M 58.5 M 57.6 M - 55.9 M 57.3 M 48.7 M 51.9 M 51 M 51.9 M 46.9 M 44.7 M 41.9 M 46.6 M 47.2 M

Operating Income

56.4 M 59.3 M 49.6 M - 58 M 54.5 M 38.7 M - 48.8 M 41.6 M 34.2 M - 29.3 M 32.7 M 22.5 M - 33.1 M 39.4 M 34.6 M - 39.8 M 9.18 M 44.1 M - 46.5 M 49.3 M 39.2 M - 41.5 M 44.4 M 30 M - 35.8 M 36.1 M 26.5 M - 36.9 M 29.3 M 11.1 M - 1.2 M 13 M 9.39 M - 16.2 M 19.5 M 22.5 M - 17 M 17.1 M 14.3 M - 2.13 M 11.1 M 11.2 M - 12.9 M 18.3 M 18 M

Interest Expense

-1.13 M -3.98 M -47.9 M - -916 K 127 K -1.01 M - -580 K -359 K 17.3 M - 10.7 M 7.77 M 5.97 M - 10.1 M 7.53 M 8.53 M - 9.37 M 9.27 M 10.4 M - 12.3 M 13.6 M 13.8 M - 54.5 M 15.2 M 15.6 M - 15.8 M 15.1 M 28.9 M - 27.9 M 27.9 M 27.6 M - 5.82 M 1.21 M 1.12 M - 1.05 M 1.07 M 1.08 M - 1.52 M 1.44 M 6.99 M - 4.4 M 4.42 M 4.36 M - 4.12 M 4.4 M 4.27 M

EBITDA

72.7 M 75.5 M 79.4 M - 71.6 M 68.1 M 64.9 M - 61.8 M 54.7 M 58.3 M - 41.4 M 45 M 45 M - 93.6 M 49.7 M 54.9 M - 98.8 M 48.3 M 63.6 M - 104 M 87.9 M 58.8 M - 110 M 92.9 M 56.4 M - 110 M 85.5 M 51.2 M - 104 M 74.3 M 33.5 M - 28.1 M 31.2 M 18.6 M - 44.1 M 38.1 M 31.8 M - 43.7 M 35 M 23.1 M - 36.2 M 33.2 M 22.3 M - 40 M 36.3 M 26.8 M

Operating Expenses

69.7 M 69.8 M 70.8 M - 58.6 M 62.9 M 69.6 M - 56.2 M 64.2 M 62.5 M - 57.5 M 60.2 M 59 M - 48.8 M 49.4 M 49.9 M - 18.2 M 48.7 M 52.6 M - 46.9 M 47.6 M 49.4 M - 50.5 M 54.4 M 53.5 M - 53.4 M 53.1 M 64.7 M - 61 M 66.8 M 80.3 M - 50.5 M 44.9 M 43 M - 41.9 M 38.9 M 35.1 M - 38.9 M 40.2 M 34.4 M - 48.8 M 40.8 M 35.7 M - 29 M 28.3 M 29.2 M

General and Administrative Expenses

50.5 M 52.9 M 51.2 M - 44.8 M 46.5 M 46.4 M - 41.4 M 45.8 M 41.9 M - 38.2 M 41.8 M 39.6 M - 34.3 M 35.4 M 35.5 M - 3.61 M 33.9 M 36.5 M - 32.9 M 33.1 M 35 M - 34.1 M 36.8 M 36.4 M - 35.1 M 35.1 M 39.5 M - 36.3 M 37.6 M 41.9 M - 22.3 M 24.1 M 22.6 M - 22.1 M 21.9 M 21.8 M - 21.6 M 22.2 M 20.1 M - 20.3 M 20.7 M 19 M - 17.8 M 17.6 M 18.6 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Integer Holdings Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Alphatec Holdings Alphatec Holdings
ATEC
$ 11.25 3.21 % $ 1.69 B usaUSA
AxoGen AxoGen
AXGN
$ 33.47 4.72 % $ 1.54 B usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Align Technology Align Technology
ALGN
$ 180.67 4.35 % $ 13.5 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 12.32 1.23 % $ 1.66 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.59 -4.08 % $ 36.7 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.33 0.76 % $ 125 M franceFrance
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 288.17 3.19 % $ 8.13 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 39.05 3.88 % $ 5.82 K usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 63.18 2.3 % $ 93.5 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.03 7.41 % $ 1.23 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 10.01 15.32 % $ 283 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.03 3.01 % $ 17.4 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Electromed Electromed
ELMD
$ 24.95 3.44 % $ 211 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Inogen Inogen
INGN
$ 6.45 1.9 % $ 172 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 64.58 2.87 % $ 3.52 B britainBritain
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
LENSAR LENSAR
LNSR
$ 5.92 3.86 % $ 70.8 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 16.95 6.14 % $ 398 M usaUSA
Globus Medical Globus Medical
GMED
$ 92.98 2.83 % $ 12.6 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.28 4.39 % $ 906 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Delcath Systems Delcath Systems
DCTH
$ 10.45 4.08 % $ 374 M usaUSA
Myomo Myomo
MYO
$ 0.73 6.34 % $ 30.6 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 54.92 1.67 % $ 1.61 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 38.46 4.68 % $ 1.19 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.71 0.16 % $ 123 M usaUSA